Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine.

[1]  T. Lawrence,et al.  Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells. , 1990, International journal of radiation oncology, biology, physics.

[2]  R K ten Haken,et al.  An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy. , 1990, International journal of radiation oncology, biology, physics.

[3]  J. Hannigan,et al.  A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A B Wolbarst,et al.  Optimization of radiation therapy, IV: A dose-volume histogram reduction algorithm. , 1989, International journal of radiation oncology, biology, physics.

[5]  G T Chen,et al.  Dose volume histograms in treatment planning. , 1988, International journal of radiation oncology, biology, physics.

[6]  P D Schneider,et al.  A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. , 1987, Annals of surgery.

[7]  N. Geller,et al.  Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. , 1987, Annals of internal medicine.

[8]  P. Desimone,et al.  Treatment of Liver Metastases with a Combination of Chemotherapy and Hyperfractionated External Radiation Therapy , 1987, American journal of clinical oncology.

[9]  A. Benson,et al.  Modulation of 5-iodo-2'-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines. , 1985, Biochemical pharmacology.

[10]  M. Buyse,et al.  Cancer Clinical Trials: Methods and Practice. , 1985 .

[11]  J. Byfield,et al.  Treatment with combined intraarterial 5‐FUdR infusion and whole‐liver radiation for colon carcinoma metastatic to the liver Preliminary results , 1984, American journal of clinical oncology.

[12]  Ensminger Wd,et al.  Clinical pharmacology of hepatic arterial chemotherapy. , 1983 .

[13]  M. Goitein,et al.  Multi-dimensional treatment planning: II. Beam's eye-view, back projection, and projection through CT sections. , 1983, International journal of radiation oncology, biology, physics.

[14]  T. Kinsella.  The role of radiation therapy alone and combined with infusion chemotherapy for treating liver metastases. , 1983, Seminars in oncology.

[15]  J. Byfield,et al.  Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-Fluorouracil or ftorafur and X rays. , 1982, International journal of radiation oncology, biology, physics.

[16]  M. Clouse,et al.  Concomitant hepatic radiation and intraarterial fluorinated pyrimidine therapy: Correlation of liver scan, liver function tests, and plasma CEA with tumor response , 1981 .

[17]  T. Phillips,et al.  Combined modality therapy of hepatic metastasis , 1979, Cancer.

[18]  Y. Nakajima,et al.  Enhancement of mammalian cell killing by 5-fluorouracil in combination with X-rays. , 1979, Cancer research.

[19]  Daniel L. McShan,et al.  A computerized three-dimensional treatment planning system utilizing interactive colour graphics. , 1979, The British journal of radiology.

[20]  D. Levin,et al.  A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. , 1978, Cancer research.

[21]  R. Gelber,et al.  The palliation of hepatic metastases: results of the Radiation Therapy Oncology Group pilot study. , 1978, International journal of radiation oncology, biology, physics.

[22]  V. Rege,et al.  A combined treatment approach to management of hepatic metastases , 1977 .

[23]  D. M. Sherman,et al.  Palliation of hepatic metastasis , 1978, Cancer.

[24]  W. Szybalski,et al.  MOLECULAR RADIOBIOLOGY OF HUMAN CELL LINES. V. COMPARATIVE RADIOSENSITIZING PROPERTIES OF 5-HALODEOXYCYTIDINES AND 5-HALODEOXYURIDINES. , 1963, Radiation research.

[25]  W. Szybalski,et al.  GENETICS OF HUMAN CELL LINES III. INCORPORATION OF 5-BROMO- AND 5-IODODEOXYHRIDINE INTO THE DEOXYRIBONUCLEIC ACID OF HUMAN CELLS AND ITS EFFECT ON RADIATION SENSITIVITY , 1960 .

[26]  C. Heidelberger,et al.  The potentiation by 5-iodo-2'-deoxyuridine (IUDR) of the tumor-inhibitory activity of 5-fluoro-2'-deoxyuridine (FUDR). , 1960, Cancer chemotherapy reports.

[27]  D. Karnofsky,et al.  Roentgen therapy of hepatic metastases. , 1954, The American journal of roentgenology, radium therapy, and nuclear medicine.

[28]  T. Lawrence,et al.  The application of 3-d treatment planning and dose volume histograms in the treatment of intrahepatic malignancies , 1989 .

[29]  J. Knol,et al.  Combination chemo-radiation therapy for jaundice due to focal malignant obstruction of the major bile ducts. , 1989, Selective cancer therapeutics.

[30]  T. Lawrence,et al.  Abstract of ASTRO scientific paper to be presentedFluorodeoxyuridine-induced radiosensitization and inhibition of dna double strand break repair in human colon cancer cells , 1989 .

[31]  G T Chen,et al.  Dose volume histogram analysis of liver radiation tolerance. , 1986, International journal of radiation oncology, biology, physics.

[32]  J. Lyman.  Complication Probability as Assessed from Dose-Volume Histograms , 1985 .

[33]  R. D. Hunter,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1980 .

[34]  L. Delclos,et al.  Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique. , 1973, The American journal of roentgenology, radium therapy, and nuclear medicine.